The Cough Suppressant Drugs Market is expected to register a CAGR of 4.4% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report on the cough suppressant drugs market is categorized by product type into opioids, non-opioids, and combination drugs. Applications include chronic cough, acute cough, and others. End-users analyzed in The report are hospitals, retail pharmacies, and online pharmacies. Regional analysis covers key markets such as North America, Europe, Asia Pacific, the Middle East and Africa, and South America. The market valuation is provided in US$ for all segmental analyses.
Purpose of the ReportThe report Cough Suppressant Drugs Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Cough Suppressant Drugs Market Segmentation
Disease Type- Dry Cough
- Wet Cough
- Over-the-counter
- Prescription Drug
- Pediatric
- Adult
- Hospital
- Retail Pharmacy
- Online Pharmacy
Strategic Insights
Cough Suppressant Drugs Market Growth Drivers- Growing Prevalence of Respiratory Disease:
Increasing asthmatic patients, chronic obstructive pulmonary diseases, bronchitis, or other related infections are promoting its demand in this market. With more than 65 million victims suffering from global moderate to serious COPD around the world and growing pollution conditions along with occasional respiratory seasonal conditions, a demand for the treatments of such illness is becoming crucial. The post-pandemic increase in respiratory health concerns has also increased the demand for prescription and over-the-counter (OTC) cough suppressants.
- The geriatric population is increasing:
Chronic respiratory conditions are more prevalent in the aging population, which include persistent cough. The United Nations estimates that by 2050, people above 65 years will be around 1.5 billion in number. Due to weakening of the immune system with age, older persons are more susceptible to respiratory ailments, thereby fueling the growth of the market for cough suppressants. Today, pharmaceutical companies are targeting gentleness and effectiveness to formulate suitable medicines for older individuals. - Technological Advancements in Drug Formulations:
Innovations in drug formulations have spawned advanced products, including fast-dissolving tablets and extended release syrups. Such technologies prolong the relief times between dosages for patients, meaning better compliance. Moreover, dissolvable films and vaporizers are also gaining ground for those not desiring a liquid-based dosing solution. Those firms that invest in R&D of innovative drug delivery systems are able to gain an edge in the marketplace over their competitors.
- Rising Demand for Natural and Herbal Products:
With growing concerns over the side effects of synthetic medications, consumers are increasingly opting for natural cough suppressants. Ingredients such as honey, ginger, and herbal extracts are preferred for their soothing properties. According to a report by the American Botanical Council, herbal supplement sales in the U.S. grew by over 10% annually, indicating a strong shift toward natural health products. Pharmaceutical companies are responding by launching herbal-based formulations to meet this demand. - Focus on Pediatric-Friendly Cough Suppressants:
The need for safe and effective cough medications for children has prompted pharmaceutical companies to develop pediatric-specific formulations. These products come in flavored syrups, chewable tablets, and dissolvable strips to ensure ease of administration. The demand for child-friendly products has increased as parents seek safer alternatives that avoid the risks associated with adult cough medications. Regulatory guidelines emphasizing pediatric safety further drive this trend. - Technological Advancements in Drug Delivery Systems:
Technological innovations are reshaping the cough suppressant market by introducing novel drug delivery systems. Fast-acting sprays, dissolvable strips, and vapor-based delivery methods provide alternative ways to administer medications. These innovations are particularly appealing to consumers seeking quick and convenient solutions. The adoption of nanotechnology in cough suppressant formulations also improves drug absorption, leading to enhanced efficacy and faster relief.
- Collaborations with Research Institutes: Pharmaceutical companies have started collaborating with research institutes in order to innovate and develop more effective and advanced cough suppressant formulations. The collaboration leads to the discovery of new drug compounds as well as the mechanism of drug delivery. Firms that spend money on collaborative research efforts would be able to outpace competition by launching better products sooner.
- Increasing Interest in E-Commerce Channels: E-commerce has significantly changed the method of medication consumption by patients for cough suppressants. Online pharmacies provide easy accessibility and convenience; they allow a customer to make a comparison among products and gain a lot of information regarding the product prior to buying. Digital healthcare services are becoming a trend, which will increase the sale of online cough remedies further. Companies strengthening their digital front can reap the benefits of this business opportunity.
- Personalized Medicine and Targeted Treatments: The trend towards personalized medication in the cough suppressant market poses a great opportunity for pharmaceutical companies. Data analytics and genetic profiling can be used to come up with targeted treatments for specific conditions in the respiratory system. Personalized formulations would provide enhanced efficacy and a lower risk of side effects, making them most attractive to health-conscious consumers. The future of the cough suppressant market will be redefined by such trends.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Cough Suppressant Drugs Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Cough Suppressant Drugs Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Cough Suppressant Drugs Market is expected to register a CAGR of 4.4% from 2025-2031.
The major driving factors supporting the Cough Suppressant Drugs market growth are - Growing Prevalence of Respiratory Disease, The Geriatric Population is Increasing, and
Technological Advancements in Drug Formulations
Key future trends in the Cough Suppressant Drugs Market are -Rising Demand for Natural and Herbal Products, Focus on Pediatric-Friendly Cough Suppressants, and Technological Advancements in Drug Delivery Systems
Key companies in the Cough Suppressant Drugs Market are- Perrigo Company plc, Vernalis, Tris Pharma, Inc., Pfizer Inc., Aytu BioScience, Inc., ACELLA PHARMACEUTICALS, LLC, Mayne Pharma Inc., Aurobindo Pharma, GlaxoSmithKline plc., Reckitt Benckiser
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1 SCOPE OF THE STUDY
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3 MARKET SEGMENTATION
1.3.1 Cough Suppressant Drugs Market- By Disease Type
1.3.2 Cough Suppressant Drugs Market- By Product Type
1.3.3 Cough Suppressant Drugs Market- By Age Group
1.3.4 Cough Suppressant Drugs Market- By Distribution Channel
1.3.5 Cough Suppressant Drugs Market- By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COUGH SUPPRESSANT DRUGS MARKET LANDSCAPE
4.1 MARKET OVERVIEW
4.2 PEST ANALYSIS
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
5. COUGH SUPPRESSANT DRUGS MARKET- KEY INDUSTRY DYNAMICS
5.1 KEY MARKET DRIVERS
5.2 KEY MARKET RESTRAINTS
5.3 KEY MARKET OPPORTUNITIES
5.4 FUTURE TRENDS
5.5 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. COUGH SUPPRESSANT DRUGS MARKET- GLOBAL ANALYSIS
6.1 COUGH SUPPRESSANT DRUGS MARKET - GLOBAL MARKET OVERVIEW
6.2 COUGH SUPPRESSANT DRUGS MARKET - GLOBAL MARKET AND FORECAST TO 2028
6.3 MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS
7. COUGH SUPPRESSANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1 OVERVIEW
7.2 DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3 DRY COUGH MARKET
7.3.1 Overview
7.3.2 Dry Cough Market Revenue Forecasts and Analysis (US$ Mn)
7.4 WET COUGH MARKET
7.4.1 Overview
7.4.2 Wet Cough Market Revenue Forecasts and Analysis (US$ Mn)
8. COUGH SUPPRESSANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
8.1 OVERVIEW
8.2 PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
8.3 OVER-THE-COUNTER (OTC) DRUGS MARKET
8.3.1 Overview
8.3.2 Over-the-counter (OTC) Drugs Market Forecast and Analysis (US$ Mn)
8.4 PRESCRIPTION DRUG MARKET
8.4.1 Overview
8.4.2 Prescription Drug Market Forecast and Analysis (US$ Mn)
9. COUGH SUPPRESSANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - AGE GROUP
9.1 OVERVIEW
9.2 AGE GROUP MARKET FORECASTS AND ANALYSIS
9.3 PEDIATRIC MARKET
9.3.1 Overview
9.3.2 Pediatric Market Forecast and Analysis (US$ Mn)
9.4 ADULT MARKET
9.4.1 Overview
9.4.2 Adult Market Forecast and Analysis (US$ Mn)
10. COUGH SUPPRESSANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3 HOSPITAL MARKET
10.3.1 Overview
10.3.2 Hospital Market Forecast and Analysis (US$ Mn)
10.4 RETAIL PHARMACY MARKET
10.4.1 Overview
10.4.2 Retail Pharmacy Market Forecast and Analysis (US$ Mn)
10.5 ONLINE PHARMACY MARKET
10.5.1 Overview
10.5.2 Online Pharmacy Market Forecast and Analysis (US$ Mn)
10.6 OTHERS MARKET
10.6.1 Overview
10.6.2 Others Market Forecast and Analysis (US$ Mn)
11. COUGH SUPPRESSANT DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1 NORTH AMERICA COUGH SUPPRESSANT DRUGS MARKET
11.1.1 North America Cough Suppressant Drugs Market Forecasts and Analysis (US$ Mn)
11.1.2 North America Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.1.3 North America Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.1.4 North America Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.1.5 North America Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.1.6 North America Cough Suppressant Drugs Market Forecasts and Analysis - By Country
11.1.7 US Market Overview
11.1.7.1 US Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.1.7.2 US Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.1.7.3 US Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.1.7.4 US Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.1.8 Canada Market Overview
11.1.8.1 Canada Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.1.8.2 Canada Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.1.8.3 Canada Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.1.8.4 Canada Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.1.9 Mexico Market Overview
11.1.9.1 Mexico Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.1.9.2 Mexico Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.1.9.3 Mexico Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.1.9.4 Mexico Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.2 EUROPE COUGH SUPPRESSANT DRUGS MARKET
11.2.1 Europe Cough Suppressant Drugs Market Forecasts and Analysis (US$ Mn)
11.2.2 Europe Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.2.3 Europe Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.2.4 Europe Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.2.5 Europe Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.2.6 Europe Cough Suppressant Drugs Market Forecasts and Analysis - By Country
11.2.7 UK Market Overview
11.2.7.1 UK Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.2.7.2 UK Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.2.7.3 UK Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.2.7.4 UK Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.2.8 Germany Market Overview
11.2.8.1 Germany Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.2.8.2 Germany Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.2.8.3 Germany Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.2.8.4 Germany Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.2.9 France Market Overview
11.2.9.1 France Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.2.9.2 France Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.2.9.3 France Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.2.9.4 France Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.2.10 Italy Market Overview
11.2.10.1 Italy Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.2.10.2 Italy Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.2.10.3 Italy Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.2.10.4 Italy Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.2.11 Spain Market Overview
11.2.11.1 Spain Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.2.11.2 Spain Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.2.11.3 Spain Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.2.11.4 Spain Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.3 ASIA PACIFIC COUGH SUPPRESSANT DRUGS MARKET
11.3.1 Asia Pacific Cough Suppressant Drugs Market Forecasts and Analysis (US$ Mn)
11.3.2 Asia Pacific Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.3.3 Asia Pacific Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.3.4 Asia Pacific Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.3.5 Asia Pacific Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.3.6 Asia Pacific Cough Suppressant Drugs Market Forecasts and Analysis - By Country
11.3.7 Japan Market Overview
11.3.7.1 Japan Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.3.7.2 Japan Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.3.7.3 Japan Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.3.7.4 Japan Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.3.8 India Market Overview
11.3.8.1 India Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.3.8.2 India Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.3.8.3 India Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.3.8.4 India Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.3.9 China Market Overview
11.3.9.1 China Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.3.9.2 China Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.3.9.3 China Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.3.9.4 China Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.3.10 South Korea Market Overview
11.3.10.1 South Korea Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.3.10.2 South Korea Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.3.10.3 South Korea Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.3.10.4 South Korea Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.3.11 Australia Market Overview
11.3.11.1 Australia Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.3.11.2 Australia Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.3.11.3 Australia Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.3.11.4 Australia Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.4 MIDDLE EAST & AFRICA (MEA) COUGH SUPPRESSANT DRUGS MARKET
11.4.1 Middle East & Africa (MEA) Cough Suppressant Drugs Market Forecasts and Analysis (US$ Mn)
11.4.2 Middle East & Africa (MEA) Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.4.3 Middle East & Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.4.4 Middle East & Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.4.5 Middle East & Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.4.6 Middle East & Africa (MEA) Cough Suppressant Drugs Market Forecasts and Analysis - By Country
11.4.7 South Africa Market Overview
11.4.7.1 South Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.4.7.2 South Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.4.7.3 South Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.4.7.4 South Africa Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.4.8 Saudi Arabia Market Overview
11.4.8.1 Saudi Arabia Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.4.8.2 Saudi Arabia Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.4.8.3 Saudi Arabia Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.4.8.4 Saudi Arabia Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.4.9 UAE Market Overview
11.4.9.1 UAE Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.4.9.2 UAE Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.4.9.3 UAE Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.4.9.4 UAE Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.5 SOUTH AND CENTRAL AMERICA COUGH SUPPRESSANT DRUGS MARKET
11.5.1 South and Central America Cough Suppressant Drugs Market Forecasts and Analysis (US$ Mn)
11.5.2 South and Central America Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.5.3 South and Central America Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.5.4 South and Central America Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.5.5 South and Central America Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.5.6 South and Central America Cough Suppressant Drugs Market Forecasts and Analysis - By Country
11.5.7 Brazil Market Overview
11.5.7.1 Brazil Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.5.7.2 Brazil Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.5.7.3 Brazil Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.5.7.4 Brazil Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
11.5.8 Argentina Market Overview
11.5.8.1 Argentina Cough Suppressant Drugs Market Forecasts and Analysis - By Disease Type (US$ Mn)
11.5.8.2 Argentina Cough Suppressant Drugs Market Forecasts and Analysis - By Product Type (US$ Mn)
11.5.8.3 Argentina Cough Suppressant Drugs Market Forecasts and Analysis - By Age Group (US$ Mn)
11.5.8.4 Argentina Cough Suppressant Drugs Market Forecasts and Analysis - By Distribution Channel (US$ Mn)
12. INDUSTRY LANDSCAPE
12.1 ORGANIC GROWTH STRATEGIES
12.1.1 New Product Launches
12.1.2 Marketing & Promotional Activities
12.2 INORGANIC GROWTH STRATEGIES
12.2.1 Partnerships, Collaborations, and Joint Ventures
12.2.2 Mergers & Acquisitions
13. COUGH SUPPRESSANT DRUGS MARKET, KEY COMPANY PROFILES
13.1 PERRIGO COMPANY PLC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 VERNALIS
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 TRIS PHARMA, INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PFIZER INC.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AYTU BIOSCIENCE, INC.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 ACELLA PHARMACEUTICALS, LLC
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 MAYNE PHARMA INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AUROBINDO PHARMA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 GLAXOSMITHKLINE PLC.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 RECKITT BENCKISER
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. APPENDIX
14.1 ABOUT THE INSIGHT PARTNERS
14.2 GLOSSARY OF TERMS
1. Perrigo Company plc
2. Vernalis
3. Tris Pharma, Inc.
4. Pfizer Inc.
5. Aytu BioScience, Inc.
6. ACELLA PHARMACEUTICALS, LLC
7. Mayne Pharma Inc.
8. Aurobindo Pharma
9. GlaxoSmithKline plc.
10. Reckitt Benckiser
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For